Envestnet Asset Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16,649
Closed -$82.9K 4566
2025
Q2
$82.9K Buy
16,649
+97
+0.6% +$421 ﹤0.01% 4357
2025
Q1
$73K Sell
16,552
-1,482
-8% -$6.96K ﹤0.01% 4272
2024
Q4
$83.9K Buy
+18,034
New +$99.1K ﹤0.01% 4231
2024
Q2
Sell
-14,261
Closed -$101K 4213
2024
Q1
$101K Sell
14,261
-452
-3% -$2.99K ﹤0.01% 4059
2023
Q4
$98.6K Buy
+14,713
New +$82.8K ﹤0.01% 3943
2023
Q2
Sell
-15,386
Closed -$2.6K 3997
2023
Q1
$2.6K Buy
+15,386
New +$85.8K ﹤0.01% 3961
2022
Q2
Sell
-51,531
Closed -$996K 3967
2022
Q1
$996K Sell
51,531
-4,639
-8% -$106K ﹤0.01% 2668
2021
Q4
$1.84M Sell
56,170
-12,984
-19% -$522K ﹤0.01% 2240
2021
Q3
$2.84M Buy
69,154
+24,956
+56% +$905K ﹤0.01% 1873
2021
Q2
$1.59M Buy
44,198
+3,285
+8% +$121K ﹤0.01% 2215
2021
Q1
$1.6M Buy
40,913
+14,942
+58% +$672K ﹤0.01% 2087
2020
Q4
$1.05M Buy
25,971
+21,706
+509% +$997K ﹤0.01% 2178
2020
Q3
$237K Buy
+4,265
New +$226K ﹤0.01% 2830

Other funds holding GDRX

Envestnet Asset Management's GDRX Position: Q3 2025 in Review

Envestnet Asset Management sold out of GoodRx Holdings (GDRX) in Q3 2025, closing a stake of 16,649 shares — an estimated $82.9K sold.

Envestnet Asset Management first reported a position in GDRX in Q3 2020 and held it in 13 quarters. The position peaked at $2.84M in Q3 2021. 161 funds tracked by Wall St. Rank hold GDRX as of Q3 2025.

  • Envestnet Asset Management reported no remaining GoodRx Holdings position as of Q3 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 16,649 GoodRx Holdings shares in Q3 2025, an estimated $82.9K.
  • Envestnet Asset Management first reported a position in GoodRx Holdings in Q3 2020 and held it in 13 quarters.
  • Envestnet Asset Management's GoodRx Holdings position peaked at $2.84M in Q3 2021.
  • 161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2025.

Based on Envestnet Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.